Premium Nahrungsergänzungsmittel | artgerecht

Tachyarrhythmia Absoluta – Causes and Treatment

Tachyarrhythmia absoluta is a form of atrial fibrillation characterized by a rapid, completely irregular heartbeat. It requires prompt medical evaluation and treatment.

Regular tips about health Regular tips about health

Things worth knowing about "Tachyarrhythmia Absoluta"

Tachyarrhythmia absoluta is a form of atrial fibrillation characterized by a rapid, completely irregular heartbeat. It requires prompt medical evaluation and treatment.

What is Tachyarrhythmia Absoluta?

Tachyarrhythmia absoluta is a clinical term for atrial fibrillation (AFib) presenting with a fast and completely irregular heart rhythm. The term combines tachycardia (elevated heart rate), arrhythmia (irregular rhythm), and absoluta (absolute, meaning entirely irregular). The heart rate typically ranges from 100 to 180 beats per minute, sometimes even higher. It is the most common clinically significant cardiac arrhythmia worldwide.

Causes

Tachyarrhythmia absoluta develops when the electrical signals in the atria (upper chambers of the heart) become chaotic and uncoordinated. Common causes include:

Coronary artery disease (narrowing of the coronary arteries)
Arterial hypertension (high blood pressure)
Heart valve disease, especially of the mitral valve
Heart failure
Hyperthyroidism (overactive thyroid gland)
Excessive alcohol or caffeine consumption
Electrolyte imbalances (e.g., low potassium levels)
Inflammatory heart conditions such as myocarditis or pericarditis
Idiopathic causes (no identifiable cause, especially in younger patients)

Symptoms

Symptoms can vary considerably depending on the severity and the presence of underlying conditions. Typical complaints include:

Rapid heartbeat or palpitations
Irregular pulse, which patients often notice themselves
Shortness of breath, especially during physical activity
Dizziness or lightheadedness
Chest pain or a feeling of pressure in the chest
Reduced exercise tolerance and fatigue
In severe cases: loss of consciousness or syncope

Some individuals have no noticeable symptoms and are only diagnosed incidentally during a routine examination.

Diagnosis

The diagnosis of tachyarrhythmia absoluta is primarily established through:

Electrocardiogram (ECG): The ECG shows a characteristic pattern with irregularly spaced RR intervals, absence of distinct P waves, and an elevated ventricular rate.
Holter ECG (ambulatory ECG monitoring): Used to detect intermittent (paroxysmal) episodes over 24 to 48 hours.
Echocardiography: Ultrasound imaging of the heart to assess cardiac structure and function, and to rule out atrial thrombi (blood clots).
Blood tests: Evaluation of thyroid function, electrolytes, and inflammatory markers.
Blood pressure measurement and clinical examination.

Treatment

Rate Control

The primary goal of treatment is often to reduce the heart rate to a normal resting range (60-100 beats per minute). Medications used include:

Beta-blockers (e.g., metoprolol, bisoprolol)
Calcium channel blockers (e.g., verapamil, diltiazem)
Cardiac glycosides (e.g., digoxin, particularly in patients with heart failure)

Rhythm Control

In selected patients, restoration of normal sinus rhythm may be attempted through:

Pharmacological cardioversion using antiarrhythmic drugs (e.g., amiodarone, flecainide)
Electrical cardioversion: Delivery of a controlled electric shock under short general anesthesia to restore normal rhythm
Catheter ablation: A minimally invasive procedure in which the trigger sites of atrial fibrillation are destroyed using radiofrequency energy or cryotherapy

Anticoagulation (Blood Thinners)

Because atrial fibrillation significantly increases the risk of stroke (blood clots can form in the atria and travel to the brain), most patients require anticoagulant therapy. Options include:

Direct oral anticoagulants (DOACs) such as apixaban, rivaroxaban, or dabigatran
Vitamin K antagonists such as warfarin or phenprocoumon

Prognosis and Course

With appropriate treatment, most patients experience a significant improvement in quality of life. The risk of stroke can be substantially reduced with consistent anticoagulation therapy. If left untreated, the condition can lead to serious complications including heart failure and stroke. Regular follow-up with a cardiologist is therefore essential.

References

Hindricks G. et al. - 2020 ESC Guidelines for the diagnosis and management of atrial fibrillation. European Heart Journal, 2021; 42(5): 373-498. (European Society of Cardiology)
Fuster V. et al. - ACC/AHA/ESC 2006 Guidelines for the Management of Patients with Atrial Fibrillation. Circulation, 2006; 114(7): 700-752.
January C.T. et al. - 2019 AHA/ACC/HRS Focused Update of the 2014 AHA/ACC/HRS Guideline for the Management of Patients With Atrial Fibrillation. Journal of the American College of Cardiology, 2019; 74(1): 104-132.

Building Blocks for a Healthy Life

As an integrated manufacturer, we develop & produce evidence-based, patented, and non-patented formulations. We work exclusively with plant and natural extracts according to the strictest purity & quality standards.
The combination of science & modern technology with the laws of nature creates solutions consistently tailored to humans – for the highest good: health.